AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$CRDO

Cheng Chi Fung sold $5.3M of CRDO (indirect holdings)

Cheng Chi Fung (Chief Technology Officer) sold 27,500 indirectly-held shares of Credo Technology Group Holding Ltd (CRDO) at an average of $193.12 ($190.03–$195.68, $5.31M total) across 7 trades on 2026-09-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cheng Chi Fung
Published Sep 25, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 8:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CRDO
Bearish
medium confidence
Mentioned
$CRDO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CRDOBearishMed
01

Why it matters

The sale reduces insider ownership and may be interpreted as a lack of confidence, prompting short interest.

02

Market read

Primary insider sale news; modest materiality for traders monitoring biotech equities.

03

What to watch

Potential upcoming catalyst (e.g., trial data) that insiders are positioning for.

Relevance 5/10Novelty 8/10Timing: post‑market 2026‑09‑23

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the CTO's sale.

Company-level read

Ticker impact

$CRDOBearishMedium confidence
Context

Chief Technology Officer sold 27,500 shares for $5.3M via a 10b5-1 plan, reducing his stake to 5.69M shares.

Expected impact

Potential short-term downside pressure of 2‑4% as the market digests the sale.

Evidence & confidence

A $5.3M sale by a senior officer is material for a mid‑cap biotech, and the 10b5‑1 plan suggests pre‑planned execution rather than panic, limiting the impact but still negative.

Market effects

Sector

May raise concerns for other biotech firms with insider sell activity.

Regional

Limited to U.S. biotech sector, no broader regional effect.

Global

Low; impact confined to CRDO and its immediate peers.

Counterpoint

What could challenge this read

The sale could be purely execution of a pre‑arranged plan, not a bearish signal.

Key entities

  • Company
    Credo Technology Group Holding Ltd

    Biotech firm listed on Nasdaq under CRDO.

  • Individual
    Cheng Chi Fung

    Chief Technology Officer and insider selling shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CRDO insider trading history →

Related articles

$CRDOMed

Credo Sinks Another 14% as Democratic Sweep Stokes “Left-Tail Event” Fears for AI

Credo Technology (CRDO) fell 14% as AI hardware stocks declined following Democratic midterm wins, raising concerns about data center buildout slowdowns. Oracle (ORCL) and Arista Networks (ANET) also dropped, despite strong AI demand. Credo's forward P/E hit a three-year low, with its next earnings report in December. Analysts expect revenue to nearly triple by fiscal 2028, but Texas data center moratoriums could impact growth.

finance.yahoo.com
$LITEMedAI 8/10

Lumentum Sinks 15% as AI Chip Selloff Deepens

Lumentum (LITE) dropped 15% as Marvell (MRVL), which is acquiring it, fell due to an AI chip selloff. The deal, set to close in 2028, values Lumentum at 4.5 Marvell shares per Lumentum share, with no price protection. Other optical stocks like Ciena (CIEN) and Credo (CRDO) also declined. Lumentum's CEO stated its parts are sold out through early 2029, with analysts predicting significant EPS growth.

finance.yahoo.com
$CRDOMed

Credo Stock Drops as MaxLinear Moves Into AEC Market

MaxLinear (MXL) aims for 20-30% share in the active electrical cable market, currently led by Credo (CRDO). Credo's stock fell 9.83% intraday. MaxLinear plans to sell Annapurna chips to cable makers, with initial revenue expected in 2027. MaxLinear's CEO estimates Credo's market share at 93-99%.

finance.yahoo.com
$CRDOHighAI 8/10

Credo Soars 7% as Super Micro’s $4 Billion Forecast Hike Signals “Increased Demand for AI Platforms”

Credo Technology's shares rose 7% following Super Micro's revised fiscal first-quarter revenue forecast, which increased by about $4 billion due to higher AI platform demand. Super Micro now expects $18.5B-$19.5B in revenue. Analysts anticipate Credo's revenue to nearly double to $2.5B by fiscal 2027. Other AI-related stocks like Lumentum, Coherent, Semtech, and Astera Labs also saw gains.

finance.yahoo.com